Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Mazzocca

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacy and Pharmacology|May 20, 2021
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacyDavide Gnocchi, Francesca Castellaneta, Gianluigi Cesari, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinomaAntonio Mazzocca, Emilia Fransvea, Francesco Dituri, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblastsAntonio Mazzocca, Francesco Dituri, Luigi Lupo, et al.
Biochimie|August 11, 2022
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinomaDavide Gnocchi, Agata Kurzyk, Antonella Mintrone, et al.
American Journal of Physiology. Cell Physiology|November 6, 2023
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunitsDavide Gnocchi, Dragana Nikolic, Francesca Castellaneta, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|November 20, 2019
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum LDavide Gnocchi, Gianluigi Cesari, Generosa Jenny Calabrese, et al.
Molecular Pharmacology|December 19, 2002
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell linesAntonio Mazzocca, Sabrina Giusti, Andrew D Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2017
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinomaCristian Turato, Anna Balasso, Vinicio Carloni, et al.
Cancer Genomics & Proteomics|July 17, 2012
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infectionRosa Divella, Antonio Mazzocca, Cosimo Gadaleta, et al.
Thrombosis Research|December 19, 2020
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver diseaseAlessandro Ciavarella, Davide Gnocchi, Carlo Custodero, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacy and Pharmacology|May 20, 2021
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacyDavide Gnocchi, Francesca Castellaneta, Gianluigi Cesari, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinomaAntonio Mazzocca, Emilia Fransvea, Francesco Dituri, et al.
Hepatology (Baltimore, Md.)|June 16, 2011
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblastsAntonio Mazzocca, Francesco Dituri, Luigi Lupo, et al.
Biochimie|August 11, 2022
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinomaDavide Gnocchi, Agata Kurzyk, Antonella Mintrone, et al.
American Journal of Physiology. Cell Physiology|November 6, 2023
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunitsDavide Gnocchi, Dragana Nikolic, Francesca Castellaneta, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|November 20, 2019
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum LDavide Gnocchi, Gianluigi Cesari, Generosa Jenny Calabrese, et al.
Molecular Pharmacology|December 19, 2002
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell linesAntonio Mazzocca, Sabrina Giusti, Andrew D Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2017
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinomaCristian Turato, Anna Balasso, Vinicio Carloni, et al.
Cancer Genomics & Proteomics|July 17, 2012
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infectionRosa Divella, Antonio Mazzocca, Cosimo Gadaleta, et al.
Thrombosis Research|December 19, 2020
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver diseaseAlessandro Ciavarella, Davide Gnocchi, Carlo Custodero, et al.
Pageof 7